Boulder Hill Capital Management LP bought a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 20,000 shares of the technology company’s stock, valued at approximately $231,000. Other institutional investors […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) shot up 3% during mid-day trading on Wednesday . The stock traded as high as $12.04 and last traded at $11.73. 53,198 shares were traded during mid-day trading, a decline of 92% from the average session volume of 628,587 shares. The stock had previously closed at $11.39. Wall […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totalling 5,310,000 shares, a decrease of 5.9% from the April 15th total of 5,640,000 shares. Based on an average daily volume of 622,100 shares, the days-to-cover ratio is […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 5,640,000 shares, a decrease of 8.6% from the March 31st total of 6,170,000 shares. Based on an average daily trading volume, of 596,400 shares, […]